A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
PHASE3
The purpose of this study is to evaluate the efficacy and safety of omarigl...
A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
PHASE3
The purpose of this study is to assess the safety and efficacy of omariglip...
Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
PHASE3
This study will examine the safety and efficacy of the addition of omarigli...
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in โฅ18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
PHASE3
This study will examine the safety and efficacy of once-weekly omarigliptin...
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
PHASE3
This trial will assess the safety and efficacy of omarigliptin (MK-3102) co...
A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
PHASE3
This trial will assess the safety and efficacy of omarigliptin (MK-3102) co...
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
PHASE3
This study will examine the safety and efficacy of the addition of omarigli...